Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease
- PMID: 24464312
- PMCID: PMC4110197
- DOI: 10.1039/c3cs60431d
Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease
Abstract
The association of the amyloid-β (Aβ) peptide with cellular membranes is hypothesized to be the underlying phenomenon of neurotoxicity in Alzheimer's disease. Misfolding of proteins and peptides, as is the case with Aβ, follows a progression from a monomeric state, through intermediates, ending at long, unbranched amyloid fibers. This tutorial review offers a perspective on the association of toxic Aβ structures with membranes as well as details of membrane-associated mechanisms of toxicity.
Figures
References
-
- Alzheimer's Association: Facts & Figures. Alzheimer’s & Dementia. 2013;9 - PubMed
-
- Hardy J, Selkoe DJ. Science. 2002;297:353–356. - PubMed
-
- Benilova I, Karran E, De Strooper B. Nat Neurosci. 2012;15:349–357. - PubMed
-
- Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. N Engl J Med. 2012;367:795–804. - PMC - PubMed
-
- Butterfield SM, Lashuel HA. Angew Chem Int Ed Engl. 2010;49:5628–5654. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
